Responsive Image

 

 

Responsive Image

Red de salud mental

Líneas de investigación

Espacio colaborativo con atención primaria
Investigación biomédica
Lehenak: coordinación de la continuidad asistencial para el acceso de pacientes al recurso primeros episodios
Trastorno mental grave
Trastornos de la personalidad
Trastorno infanto-juvenil
Adicciones
Suicidio
Psicogeriatría y discapacidad intelectual
Psicofarmacología

Foto grupo

Actividades del grupo:

El Grupo de Investigación en Salud Mental está integrado por profesionales de los distintos dispositivos que conforman la Red de Salud Mental de Bizkaia  (RSMB) y tiene como objetivo desarrollar y potenciar  la investigación en una serie de Líneas estratégicas en el área de la salud mental, que posibilite generar conocimiento, para mejorar la efectividad y eficiencia de los servicios que la Red presta y nos permita prepararnos ante los retos asistenciales que en un futuro deberemos abordar como organización sanitaria.

Cada línea de investigación planteada  cuenta con un responsable o referente y dentro de las mismas se pretende abordar todos aquellos aspectos que están relacionados con,  la atención sociosanitaria, epidemiología, promoción- prevención y la efectividad-eficiencia de los dispositivos e intervenciones en salud mental.

Proyectos activos:

Evaluación de la recuperación en la atención a las personas con Trastorno Mental Grave en la Red de Salud Mental de Bizkaia

Adecuación del uso de Citalopram y Escitalopram en residencias de ancianos a las dosis marcadas en ficha técnica

Plan integral de salud mental para la coordinación del trastorno mental común.

Vademécum psicofarmacológico para personas con discapacidades del desarrollo. Fichas informativas para familiares y tutores y elaboración de hojas informativas para los pacientes.

Identificación de las actividades de enfermería en la intervención de prevención de recaídas en personas con enfermedad crónica.

Estudio de la eficacia de la terapia cognitivo conductual en la disminución de los síntomas negativos, mejora de funcionalidad y disminución de la discapacidad en pacientes con esquizofrenia.

Polimorfismos en MicroARNs y genes de riesgo para esquizofrenia y trastorno bipolar. Relación con el diagnóstico y los fenotipos clínicos.

Coordinador/a del grupo



Miembros del grupo

  Francisco Javier Ballesteros Rodríguez
 
  Miguel Ángel Landabaso Vázquez
 
 
  Maider Sánchez Pérez
 
 
  María Irene Rodríguez Marañón
 
 
  Fernando González Serrano
 
 
  Maria José Zardoya Mateo
 
 
  Beatriz Corcostegui Santiago
 
 
  Jon García Ormaza
 
 
  María Aurora Arrue Ulles
 
  |   844746
  Maider Prieto Etxebeste
 
 
  Luis Pacheco Yáñez
 
 
  María Isabel Zamalloa Jauregui
 
  |   844746
  Eskarne Zallo Atxutegi
 
 
  Ainara Arnaiz Muñoz
 
 
  Leire Erkoreka González
 
 
  Manuel Hernanz Ruiz
 
 
  Virginia Guillen Cañas
 
  Patxi Gil López
 
 
  Ana María Fernández Cagigas
 
 
  Patricia Caballero Martínez
 
 
  Beatriz García Moratalla
 
 
  Juan Medrano Albeniz
 
 
  José Juan Uriarte Uriarte
 
 
  María Concepción Moreno Calvete
 
 
  María Teresa Moreno Calle
 
 
  Aranzazu Iribarren Corera
 
 
  Ane Sarasola Gandariasbeitia
 
 
  Elena Marín Díaz-Guardamino
 
 
  José Ignacio Landaluce Lauzurica
 
 
  Rodrigo Joaquín Oraa Gil
 
 
  Fernando Lázaro Perlado
 
 
  Olga Olivas Gallego
 
 
  Noemí Varela Gómez
 
 
  Nerea Durán Núñez
 
 
  María Ángeles Irastorza Abans
 
 
  Myrian García Ruiz
 
 
  Irati Armentia Marín
 
 
  Verónica Sanmartín Cuevas
 
 
  María Begoña Rueda Ruiz
 
 
  Nerea Jauregizar Albonigamayor
 
 
  Alicia Loureiro González
 
 
  Pedro Muñoz Domínguez
 
 
  Raúl Sancho Echevarria
 

Publicaciones del grupo

Moreno Calvete MC, Uriarte JJ, Penas P. Evidence-based practice in mental health. Enferm Clin. 2022; 32(1): 66-67. DOI:10.1016/j.enfcli.2021.06.004.

Pico N, Jung HR, Medrano J, Abayebas M, Kim DY, Hwang JH, et al. Climbing control of autonomous mobile robot with estimation of wheel slip and wheel-ground contact angle. J Mech Sci Technol. 2022; 36(2): 959-968. DOI:10.1007/s12206-022-0142-6.

Moreno Calvete MC, Uriarte JJ, Penas P. Evidence-based practice in mental health. Enferm Clin (Engl Ed). 2022; 32(1): 66-67. DOI:10.1016/j.enfcle.2021.06.003.

Illarregi U, Telleria J, Bilbao Aldaiturriaga N, Lopez E, Ballesteros J, Martin Guerrero I, et al. lncRNA deregulation in childhood acute lymphoblastic leukemia: A systematic review. Int J Oncol. 2022; 60(5). DOI:10.3892/ijo.2022.5348.

Catalan A, Aymerich C, Bilbao A, Pedruzo B, Perez JL, Aranguren N, et al. Psychosis and Substance Abuse increase the COVID-19 mortality risk. Psychol Med. 2022. DOI:10.1017/S0033291722000976.

Martinez E, Buesa I, Guillen V, Azkue JJ. Short-term improvements in the body schema can modulate pain perception in fibromyalgia syndrome. Clin Exp Rheumatol. 2022; 40(6): 1127-1135. DOI:10.55563/clinexprheumatol/2vn0uh.

Saez E, Erkoreka L, Moreno Calle T, Berjano B, Gonzalez Pinto A, Basterreche N, et al. Genetic variables of the glutamatergic system associated with treatment-resistant depression: A review of the literature. World J Psychiatr. 2022; 12(7): 884-896. DOI:10.5498/wjp.v12.i7.884.

Moreno Calvete MC, Ballesteros Rodriguez FJ. Non-pharmacological strategies for self-directed and interpersonal violence in people with severe mental illness: a rapid overview of systematic reviews. Bmj Open. 2021; 11(1): 43576-43576. DOI:10.1136/bmjopen-2020-043576.

Escudero J, Munoz JL, Morera Herreras T, Hernandez R, Medrano J, Domingo Echaburu S et al. Antipsychotics as environmental pollutants: An underrated threat?. Sci Total Environ. 2021; 769: 144634-144634. DOI:10.1016/j.scitotenv.2020.144634.

Gonzalez Fraile E, Ballesteros J, Rueda J, Santos Zorrozua B, Sola I, McCleery J. Remotely delivered information, training and support for informal caregivers of people with dementia. Cochrane Database Syst Rev. 2021; 1(1): 6440-6440. DOI:10.1002/14651858.CD006440.pub3.

Arnaiz A, Zumarraga M, Erkoreka L, Olivas O, Arrue A, Zamalloa MI et al. Factors influencing the effect of aripiprazole on prolactin levels in patients treated with risperidone or paliperidone. Sex seems to matter. Schizophr Res. 2021; 228: 382-384. DOI:10.1016/j.schres.2021.01.012.

Lertxundi U, Domingo Echaburu S, Hernandez R, Medrano J, Orive G. Venlafaxine and desvenlafaxine to be included in the surface water Watch List. Aust N Z J Psychiatry. 2021; 55(11): 1112-1112. DOI:10.1177/0004867421998787.

Recio Barbero M, Segarra R, Zabala A, Gonzalez Fraile E, Gonzalez Pinto A, Ballesteros J. Cognitive Enhancers in Schizophrenia: A Systematic Review and Meta-Analysis of Alpha-7 Nicotinic Acetylcholine Receptor Agonists for Cognitive Deficits and Negative Symptoms. Front Psychiatry. 2021; 12: 631589-631589. DOI:10.3389/fpsyt.2021.631589.

Basterreche N, Arrue A, Arnaiz A, Olivas O, Zumarraga M. Lithium: An old treatment for a new indication. Actas Esp Psiquiatr. 2021; 49(3): 122-127

Penas P, Uriarte J, Gorbena S, Slade M, Moreno Calvete M, Iraurgi I. Discrepancy between experience and importance of recovery components in the symptomatic and recovery perceptions of peoplewith severe mental disorders. BMC Psychiatry. 2021; 21(1): 277-277. DOI:10.1186/s12888-021-03287-y.

Garcia Ribas G, Garcia Arcelay E, Montoya A, Maurino J, Ballesteros J. Quantifying Knowledge of Alzheimer's Disease: An Analysis of the Psychometric Properties of the Alzheimer's Disease Knowledge Scale. Neurol Ther. 2021; 10(1): 213-224. DOI:10.1007/s40120-021-00230-x.

Erkoreka L, Zamalloa I, Rodriguez S, Munoz P, Mendizabal I, Zamalloa MI et al. Attachment anxiety as mediator of the relationship between childhood trauma and personality dysfunction in borderline personality disorder. Clin Psychol Psychother. 2021; 29(2): 501-511. DOI:10.1002/cpp.2640.

Basterreche N, Arrue A, Arnaiz A, Olivas O, Zumarraga M. CLINICAL NOTE: Lithium: An old treatment for a new indication. Actas Esp Psiquiatr. 2021; 49(3): 125-127

Saposnik G, Bueno Gil G, Sempere AP, Rodriguez Antiguedad A, del Rio B, Baz M et al. Regret and Therapeutic Decisions in Multiple Sclerosis Care: Literature Review and Research Protocol. Front Neurol. 2021; 12. DOI:10.3389/fneur.2021.675520.

Meca Lallana JE, Maurino J, Perez Miralles F, Forero L, Sepulveda M, Calles C et al. Quantifying the patients perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire. PLoS One. 2021; 16(7): 255317-255317. DOI:10.1371/journal.pone.0255317.

Erkoreka L, Zumarraga M, Arrue A, Zamalloa MI, Arnaiz A, Olivas O et al. Genetics of adult attachment: An updated review of the literature. World J Psychiatry. 2021; 11(9): 530-542. DOI:10.5498/wjp.v11.i9.530.

Pascual FS, Munoz A, Oraa R, Florez G, Notario P, Seijo P et al. Perception of a New Prolonged-Release Buprenorphine Formulation in Patients with Opioid Use Disorder: The PREDEPO Study. Eur Addict Res. 2021; 28(2): 1-12. DOI:10.1159/000520091.

Argaluza J, Domingo Echaburu S, Orive G, Medrano J, Hernandez R, Lertxundi U. Environmental pollution with psychiatric drugs. World J Psychiatry. 2021; 11(10): 791-804. DOI:10.5498/wjp.v11.i10.791.

Muela A, Balluerka N, Sansinenea E, Machimbarrena JM, Garcia Ormaza J, Ibarretxe N et al. A Social-Emotional Learning Program for Suicide Prevention through Animal-Assisted Intervention. Animals. 2021; 11(12). DOI:10.3390/ani11123375.

Erkoreka L, Basterreche N, Olivas O, Arnaiz A, Zamalloa MI, Moreno Calle T et al. Plasma gamma-aminobutiric acid levels in schizophrenia patients: correlation with positive, negative and global impression symptom severity. Eur Neuropsychopharmacol. 2021; 53: 112-113. DOI:10.1016/j.euroneuro.2021.10.151.

Gallego OO, Basterreche N, Arnaiz A, Erkoreka L, Zamalloa MI, Moreno MT et al. Polymorphisms in dopamine d2 receptor gene are associated with obesity in antipsychotic treatment patients: no relationship with eating habits changes. Eur Neuropsychopharmacol. 2021; 53: 219-219. DOI:10.1016/j.euroneuro.2021.10.285.

Unzueta Larrinaga P, Ibarra Lecue I, Barrena Barbadillo R, Diez Alarcia R, Landabaso MA, Mendibil B et al. Cannabis abuse differently regulates 5-HT2A receptors and Akt protein in platelets of subjects with schizophrenia. Eur Neuropsychopharmacol. 2021; 53: 666-667. DOI:10.1016/j.euroneuro.2021.10.763.

Arellano JJR, Zallo F, Gardenal E, Rodriguez Carrillo M, Ramirez Penas O, Arrue A et al. Generalized and concomitant astrocytic atrophy in sporadic and familiar Alzheimer's disease. Eur Neuropsychopharmacol. 2021; 53: 539-540. DOI:10.1016/j.euroneuro.2021.10.806.

Viada C,Bouza C,Fors M,Frias A,Alvarez M,Garcia L,Wilkinson B,Rodriguez C,Crombet T,Ballesteros J. Underlying dimensions of the EORTC QLQ-C30 in a Cuban population of patients with advanced non-small cell lung cancer. Qual. Life Res. 2020. 29. (12):p. 3441-3448. IF:4,147. (1).

Arietaleanizbeaskoa MS,Sancho A,Olazabal I,Moreno C,Gil E,Garcia A,Mendizabal N,de la Fuente I,Domínguez S,Pablo S,Grandes G,EfiKroniK G. Effectiveness of physical exercise for people with chronic diseases: the EFIKRONIK study protocol for a hybrid, clinical and implementation randomized trial. BMC Fam. Pract. 2020. 21. (1):p. 227-227. IF:2,022. (2).

Moreno MC,Ruiz I,Uriarte JJ. Scoping review protocol on non-pharmacological interventions for interpersonal and self-directed violence in adults with severe mental illness. Bmj Open. 2020. 10. (9):p. 37006-37006. IF:2,692. (2).

Rodriguez JM,Setien E,Suarez P,Mayoral Van Son J,Vazquez J,Gil P,Crespo B,Ayesa R,PAFIP G. Ten-year course of cognition in first-episode non-affective psychosis patients: PAFIP cohort. Psychol Med. 2020. p. 1-10. IF:5,811. (1).

Basterreche N,Arrue A,Arnaiz A,Olivas O,Zumarraga M. Repeat episode of late-onset psychosis associated with efavirenz. Actas Esp. Psiquiatr. 2020. 48. (4):p. 181-90. IF:1,196. (4).

Erkoreka L,Zamalloa I,Munoz P,Rodriguez S,Arrue A,Zamalloa MI,Macias MI,Zumarraga M,Gonzalez MA. Impact of parental psychopathology in the attachment style of cluster b personality disorders. Eur Psychiatry. 2020. 63. p. 202-203. IF:5,361. (1).

Moreno MC. The risk factors of self-directed violence in severe mental illness. A scoping review. Eur Psychiatry. 2020. 63. p. 569-569. IF:5,361. (1).

Erkoreka L,Ozamiz N,Ruiz O,Ballesteros J. Assessment of Psychiatric Symptomatology in Bilingual Psychotic Patients: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health. 2020. 17. (11):4137. IF:3,390. (1).

Meca J,Maurino J,Angel Hernandez M,Sempere AP,Brieva L,Garcia E,Terzaghi M,Saposnik G,Ballesteros J. Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing-Remitting Multiple Sclerosis: Quantifying the Patient's Perspective. Neurol. Ther. 2020. 9. (1):p. 173-179. IF:5,814. (1).

Perez M,Amayra I,Lazaro E,Garcia M,Martinez O,Caballero P,Berrocoso S,Lopez JF,Al M,Rodriguez AA,Luna P,Varona L. Intrusion errors during verbal fluency task in amyotrophic lateral sclerosis. PLoS One. 2020. 15. (5):e0233349. IF:3,240. (2).

Erkoreka L,Zamalloa I,Rodriguez S,Muñoz P,Catalan A,Arrue A,Zamalloa MI,Gonzalez MA,Zumarraga M. Genetic modulation of facial emotion recognition in borderline personality disorder. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2020. 99. p. 109816-109816. IF:5,067. (1).

Varela L,Fernández BM,Navas E,Mestres CA,Muñoz P,Cuerpo G,Rodríguez H,Montejo M,Rodríguez R,Gutiérrez F,Goenaga MA,Quintana E,Ojeda G,de Alarcón A,Vidal L,Centella T,López J,Members G,Sánchez F,Noureddine M,Rosas G,de la Torre J,Blanco R,Boado MV,Campaña M,Crespo A,Goikoetxea J,Iruretagoyena JR,Zuazabal JI,López L,Montejo M,Nieto J,Rodrigo D,Rodríguez R,Vitoria Y,Voces R,Georgieva RI,Ojeda G,Rodríguez I,Ruiz J,Cuende AM,Echeverría T,Fuerte A,Gaminde E,Ángel M,Idígoras P,Iribarren JA,Yarza AI,Urkola X,Reviejo C,Carrasco R,Climent V,Llamas P,Merino E,Plazas J,Reus S,Álvarez N,Bravo JM,Castelo L,Cuenca J,Llinares P,Miguez E,Rodríguez M,Sánchez E,Regueiro DS,Regueiro FJ,del Mar M,Castro B,García D,del Carmen M,Miguel MA,Lacalzada J,Nassar I,Plata A,Reguera JM,Asensi V,Costas C,de la Hera J,Fernández J,Iglesias L,Arguero VL,López J,Mencia P,Morales C,Moreno A,Palomo C,Paya B,Esteban ÁR,Rodríguez R,Telenti M,Almela M,Ambrosioni J,Azqueta M,Brunet M,Bodro M,Cartañá R,Falces C,Fita G,Fuster D,García de la Mària C,García D,Hernández M,Llopis J,Marco F,Miró JM,Moreno A,Nicolás D,Ninot S,Quintana E,Paré C,Pereda D,Pericás JM,Pomar JL,Ramírez J,Rovira I,Sandoval E,Sitges M,Soy D,Téllez A,Tolosana JM,Vidal B,Vila J,Adán I,Bermejo J,Bouza E,Celemín D,Cuerpo G,Delgado A,García A,García ME,González V,Kestler M,Hualde AM,Marín M,Martínez M,Muñoz P,Rincón C,Rodríguez H,Rodríguez M,Pinilla B,Pinto Á,Valerio M,Vázquez P,Verde E,Antorrena I,Loeches B,Martín A,Moreno M,Ramírez U,Rial V,Romero M,Saldaña A,Agüero J,Armiñanzas C,Arnaiz A,Arnaiz de las Revillas F,Cobo M,Carmen M,Fariñas C,Gómez R,García I,González C,Gutiérrez M,Gutiérrez J,Pajarón M,Antonio J,Teira R,Zarauza J,Domínguez F,García P,González J,Fernández A,Orden B,Ramos A,Centella T,Manuel J,Luis J,Martín P,Navas E,Oliva E,del Río A,Rodríguez J,RuizManuel S,Almendro M,Araji O,Miguel J,Calvo R,de Cueto M,Gálvez J,Méndez I,Morales I,López LE,de Alarcón A,García E,Haro JL,Lepe JA,López F,Luque R,Alonso LJ,Azcárate P,Azcona JM,Ramón J,Cabrera A,García L,Antonio J,Sanz M,de Benito N,Gurguí M,Pacho C,Pericas R,Pons G,Álvarez M,Fernández AL,Martínez A,Prieto A,Regueiro B,Tijeira E,Vega M,Canut A,Cordo J,Gainzarain JC,García O,Martín A,Ortiz de Zárate Z,Urturi JA,García G,Sánchez A,Arribas MªJ,García E,Hernández A,Blázque A,de la Morena G,Alonso Á,Aramburu J,Calvo FE,Moreno A,Tarabini P,Heredero E,Maicas C,Largo J,Sepúlveda MA,Toledano P,Iqbal SZ,Cascales E,Keituqwa I,Navarro J,Peláez A,Moreno E,Peña A,Sánchez V,Vinuesa D,Arrizabalaga M,Cifuentes C,Núñez J,Pérez MC,Villoslada A,Aured C,Fernández N,García P,Matamala M,Palacián MP,Porres JC,Alcaraz B,Cobos N,Jesús Del Amor Espín M,Antonio Giner Caro J,Jiménez R,Jimeno A,Ortín A,Viqueira M,Pericás P,Ribas MÁ,de Gopegui ER,Vidal L,Bellón MC,Escribano E,Tercero A,Segura JC,Badía C,Boix L,Xercavins M,Ibars S,Gómez E,Horcajada I,Menduiña I,Marrero H,de Miguel I,Pisos E. Prognostic assessment of valvular surgery in active infective endocarditis: multicentric nationwide validation of a new score developed from a meta-analysis. Eur. J. Cardio-Thorac. Surg. 2020. 57. (4):p. 724-731. IF:3,486. (1).

Lertxundi U,Hernández R,Medrano J,Orive G. Drug pollution and pharmacotherapy in psychiatry: A "platypus" in the room. Eur Psychiatry. 2020. 63. (1):e33. IF:5,361. (1).

Uriarte JJ,Penas P,Moreno MC,Ridgway P,Iraurgi I. Evidence of psychometric adequacy of the Spanish Adaptation of REE: Recovery Enhancing Environment. Actas Esp. Psiquiatr. 2020. 48. (2):p. 75-88. IF:1,196. (4).

Inchausti L,Gorostiza I,Gonzalez MA,Oraa R. Diagnostic stability in substance-induced psychosis. Rev. Psiquiatr. Salud Ment. 2020. IF:3,318. (3).

Penas P,Uriarte JJ,Gorbena S,Moreno MC,Ridgway P,Iraurgi I. Psychometric Adequacy of Recovery Enhancing Environment (REE) Measure: CHIME Framework as a Theory Base for a Recovery Measure. Front. Psychiatry. 2020. 11. p. 595-595. IF:4,157. (2).

Morentin B,Suarez MP,Monzo A,Ballesteros J,Molina P,Lucena J. Sports-related sudden cardiac death in Spain. A multicenter, population-based, forensic study of 288 cases. Rev Esp Cardiol (Engl Ed). 2020. 74. (3):p. 225-232. .

Basterreche N,Arrue A,Arnaiz A,Olivas O,Zumarraga M. Repeat episode of late-onset psychosis associated with efavirenz. Actas Esp. Psiquiatr. 2020. 48. (4):IF:1,196. (4).

Guillen V,Rueda JR,Lopez M,Sola I,Ballesteros J. Apomorphine for the Treatment of Erectile Dysfunction: Systematic Review and Meta-Analysis. Arch. Sex. Behav. 2020. 49(8):p. 2963-2979. IF:4,507. (1).

Lertxundi U., Erezuma I., Hernandez R., Medrano J., Garcia M., Aguirre C.. Antipsychotics and pituitary tumors: An analysis of the European pharmacovigilance database (EudraVigilance). Int Clin Psychopharmacol. 2019; 34(2): 89 - 92. FI: 1,638(Q3). DOI: 10.1097/YIC.0000000000000247.

Penas, Patricia, Iraurgi, Ioseba, Concepcion Moreno, M., Uriarte, Jose J.. How is evaluated mental health recovery?: A systematic review. Actas Esp. Psiquiatri.. 2019; 47(1): 23 - 32. FI: 1,479(Q3). DOI: .

Munoz Garcia, Gisela, Sanchez Martinez de Luna, Maria del Mar, Eskubi Goienetxe, Izaskun, Arrieta Echeita, Goizalde, Perez Fernandez, Jose Luis, Landaluce Lauzurica, Jose Ignacio, Lopez Aguayo, Mercedes, Bilbao Bilbao, Itziar, Ayuso Gallardo, Almudena, Vazquez Ingelmo, Montserrat, Herran, Sara, Munoz Cano, Ramon, Gallo Fernandez, Inaki. Design and implementation of an inter-institutional pilot project for the socio-sanitary-educational integration of children with complex chronic diseases and other special needs (EVAI: Integrated care assessment team). Int. J. Integr. Care. 2019; 19(1). FI: 2,489(Q2). DOI: 10.5334/ijic.s3451.

Gonzalez Serrano, Fernando, Basabe Homobono, Amaya Estibaliz, Panera Uribe, Consuelo, Garran Sabando, Encarnacion, Etxebarria Izaguirre, Izaskun, Garcia Ruiz, Myrian, Lopez Rodriguez, Carmen. Detection and psychotherapeutic treatment of perinatal depression. Int. J. Integr. Care. 2019; 19(1). FI: 2,489(Q2). DOI: 10.5334/ijic.s3112.

Uriarte Uriarte, Jose Juan, Penas Moran, Patricia, Moreno Calvete, Concepcion. Evaluation of the recovery model in the Bizkaia Mental Health Network. Int. J. Integr. Care. 2019; 19(1). FI: 2,489(Q2). DOI: 10.5334/ijic.s3395.

Garcia-Alonso, Carlos R., Almeda, Nerea, Salinas-Perez, Jose A., Gutierrez-Colosia, Mencia R., Uriarte-Uriarte, Jose J., Salvador-Carulla, Luis. A decision support system for assessing management interventions in a mental health ecosystem: The case of Bizkaia (Basque Country, Spain). PLoS One. 2019; 14(2): e0212179. FI: 2,776(Q2). DOI: 10.1371/journal.pone.0212179.

Arrue, Aurora, Angel Gonzalez-Torres, Miguel, Basterreche, Nieves, Arnaiz, Ainara, Olivas, Olga, Isabel Zamalloa, M., Erkoreka, Leire, Catalan, Ana, Zumarraga, Mercedes. GAD1 gene polymorphisms are associated with bipolar I disorder and with blood homovanillic acid levels but not with plasma GABA levels. NEUROCHEM INT. 2019; 124: 152 - 161. FI: 3,994(Q2). DOI: 10.1016/j.neuint.2019.01.004.

Moreno-Calvete, M. C., Gonzalez-Fraile, E., Uriarte-Uriarte, J. J., Ruiz-Ibanez, I., Santos, B., Ballesteros, J.. Which are the risk factors of violence in mental illness? A scoping review. Eur. Psychiat.. 2019; 56: 444 - 445. FI: 3,941(Q1). DOI: .

Ayesa-Arriola, Rosa, Tordesillas-Gutierrez, Diana, Setien-Suero, Esther, Remon-Gallo, Diego, Garcia Gonzalez, Maria del Carmen, Albacete, Auria, Blanco-Campal, Alberto, Manuel Rodriguez-Sanchez, Jose, Crespo-Facorro, Benedicto. Verbal Memory and Voxel Based Morphometry in First Episode Non-Affective Psychosis: A Process Oriented Approach. Neuropsychology. 2019; 33(4): 568 - 580. FI: 2,477(Q2). DOI: 10.1037/neu0000540.

Morata, L., Cobo, J., Fernandez-Sampedro, M., Guisado Vasco, P., Ruano, E., Lora-Tamayo, J., Sanchez Somolinos, M., Gonzalez Ruano, P., Rico Nieto, A., Arnaiz, A., Estebanez Munoz, M., Jimenez-Mejias, M. E., Lozano Serrano, A. B., Munez, E., Rodriguez-Pardo, D., Argelich, R., Arroyo, A., Barbero, J. M., Cuadra, F., Del Arco, A., del Toro, M. D., Guio, L., Jimenez-Beatty, D., Lois, N., Martin, O., Martinez Alvarez, R. M., Martinez-Marcos, F. J., Porras, L., Ramirez, M., Vergas Garcia, J., Soriano, A.. Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint Infections. Antimicrob. Agents Chemother.. 2019; 63(5): e02280-18. FI: 4,715(Q1). DOI: 10.1128/AAC.02280-18.

Javier Sanz-Fuentenebro, Francisco, Uriarte Uriarte, Jose Juan, Bonet Dalmau, Pere, Molina Rodriguez, Vicente, Bernardo Arroyo, Miquel. Pattern of use of clozapine in Spain. Variability and under -prescription. Rev Psiquiatr Salud Ment. 2019; 12(3): 151 - 162. FI: 2,927(Q2). DOI: 10.1016/j.rpsm.2018.02.005.

Olazagoitia-Garmendia, A., Rodriguez, J., Bilbao, J., Castellanos-Rubio, A.. An inflammation-related SNP in XPO1 5 ` UTR regulates protein amount by altering m6A mRNA methylation. Eur. J. Hum. Genet.. 2019; 27(1): 627 - 627. FI: 3,650(Q2). DOI: .

Lertxundi, Unax, Hernandez, Rafael, Medrano, Juan. The impact of the ambiguous definition of ``month'' on pharmacotherapy. Med. Hypotheses. 2019; 129: 109258 - 109258. FI: 1,322(Q4). DOI: 10.1016/j.mehy.2019.109258.

Domingo-Echaburu, S, Lertxundi-Etxebarria, U, Hernandez-Palacios, R, Medrano-Albeniz, J. Comments on the Anticholinergic Burden Calculator Web Tool. Farm. Hosp.. 2019; 43(5): 168 - 169. FI: (Q). DOI: 10.7399/fh.11298.

Arnaiz Munoz, A., Olivas, O., Erkoreka, L., Gaton, M. A., Barreiro, A., Rodriguez, J., Arrue, A., Basterreche, N., Zumarraga, M.. Factors affecting the efficacy of adjunctive aripiprazole in risperidone- or paliperidone-induced hyperprolactinemia. Eur. Neuropsychopharmacol.. 2019; 29(6): 125 - 126. FI: 4,468(Q1). DOI: 10.1016/j.euroneuro.2019.09.208.

Recio-Barbero, M., Zabala, A., Segarra, R., Santos, B., Ballesteros, F. J.. Cognitive enhancers in schizophrenia: A meta-analysis of Alpha-7 nicotinic acetylcholine receptor agonists for cognitive deficits and negative symptoms. Eur. Neuropsychopharmacol.. 2019; 29(6): 465 - 466. FI: 4,468(Q1). DOI: 10.1016/j.euroneuro.2019.09.657.

Gallego, OO, Arrue, A, Arnaiz, A, Basterreche, N, Erkoreka, L, Varela, N, Devesa, MC, Zamalloa, MI, Zumarraga, M. Genetic variants associated with low dopaminergic activity relate to parameters included in the metabolic syndrome after treatment with antipsychotics. Eur. Neuropsychopharmacol.. 2019; 29: 154 - 155. FI: 4,468(Q1). DOI: 10.1016/j.euroneuro.2019.09.244.

 

Lertxundi U, Hernandez R, Medrano J, Domingo-Echaburu S, Garcia M, Aguirre C. Aripiprazole and impulse control disorders: higher risk with the intramuscular depot formulation? Int. Clin. Psychopharmacol. 2018; 33(1): 56 - 58. FI: 2,284(Q3). DOI: 10.1097/YIC.0000000000000194.

Sánchez M, Castiella A, Zapata E, Zubiaurre L, Pérez-Yeboles J, Mendibil L, et al. Autoimmune Hepatitis (Immune-Mediated Liver Injury) Induced By Rosuvastatin. Gastroenterol. Hepatol. 2018; 41(5): 311 - 313. MEETING ABSTRACT.

Santos B, Gonzalez-Fraile E, Zabala A, Guillen V, Rueda JR, Ballesteros J. Cognitive improvement of acetylcholinesterase inhibitors in schizophrenia. J. Psychopharmacol. 2018; 32(11): 1155 - 1166. FI: 4,738 (Q1). DOI: 10.1177/0269881118805496. REVIEW.

Lertxundi U, Hernandez R, Corcóstegui B, Ibarra O, Mentxaka G, Medrano J. Influence of an inconsistent appearance of antipsychotics on drug adherence in patients with schizophrenia. Medicine (Baltimore). 2018; 97(44): e12990. FI: 2,028(Q2). DOI: 10.1097/MD.0000000000012990.

Peña J, Ibarretxe-Bilbao N, Sánchez P, Uriarte JJ, Elizagarate E, Gutierrez M, et al. Mechanisms of functional improvement through cognitive rehabilitation in schizophrenia. J. Psychiatr. Res. 2018; 101: 21 - 27. FI: 4,000(Q1). DOI: 10.1016/j.jpsychires.2018.03.002.

Lertxundi U, Hernandez R, San Miguel S, Corcostegui B, Prieto M, Gonzalez U, et al. The burden of constipation in psychiatric hospitals. Int. J. Psychiat. Clin. 2018; 22(2): 143 - 150. FI: 1,337(Q4). DOI: 10.1080/13651501.2017.1384023.

Erkoreka L, Zumárraga M, Macías I, Angel Gonzalez-Torres M. The COMT Val158Met polymorphism exerts a common influence on avoidant attachment and inhibited personality, with a pattern of positive heterosis. Psychiatry Res. 2018; 262: 345 - 347. FI: 2,223(Q2). DOI: 10.1016/j.psychres.2017.07.053. LETTER.

Chung Y, Salvador-Carulla L, Salinas-Pérez JA, Uriarte-Uriarte JJ, Iruin-Sanz A, García-Alonso CR. Use of the self-organising map network (SOMNet) as a decision support system for regional mental health planning. Health Res. Policy Syst. 2018; 16(1): 35 - 35. FI: 2,179(Q2). DOI: 10.1186/s12961-018-0308-y.

Sanz-Fuentenebro J, Uriarte-Uriarte F, Bonet-Dalmau P, Molina-Rodriguez V, Lubeiro Juarez A, Bernardo Arroyo M. Variability and underutilisation of Clozapine in Spain. Schizophr. Bull. 2018; 44(1): 205 - 205. MEETING ABSTRACT.

Trincado S, Gonzalez L, Uriarte O, Ruiz-de Azua T, Peralta D, Montero G, et al. Vitamin D levels in inpatients. Eur. Psychiat. 2018; 48: 490 - 490. . MEETING ABSTRACT.

 

Arnaiz A, Zumarraga M, Olivas O, Arrue A, Gaton M, Erkoreka L, et al. Adjunctive aripiprazole in the treatment of risperidone/paliperidone-induced hyperprolactinemia. Influence of catechol-O-methyltransferase and MAOA polymorphisms. Eur Neuropsychopharmacol. 2017;27:653-4. FI:4,239(Q1). DOI:10.1016/S0924-977X(17)31223-3. ABSTRACT

Basterreche N, Arrue A, Arnaiz A, Erkoreka L, Peralta D, Zumarraga M. Mania preceding pancreatic cancer. Actas Esp Psiquiatri. 2017;45:43-6. FI:1,339(Q3).

Bilbao A, Garcia-Perez L, Retolaza-Balsategui A, Mendezona-Pena JI, Estebanez S, de la Torre-Escalera PV, et al. Psychometric properties of the EQ-5D-5L in patients with major depression disorder. Value Health. 2017;20:758. FI:4,235(Q1). DOI:10.1016/j.jval.2017.08.2141. ABSTRACT

Bilbao A, Garcia-Perez M, Martin-Fernandez J, Retolaza-Balsategui A, Arrasate M, Sordo T, et al. Mapping from the Bdi-Ii to the Eq-5d-5l Questionnaire in patients with major depression disorder. Value Health. 2017;20:755-6. FI:4,235(Q1). ABSTRACT

Erkoreka L, Navarro B. Vulnerable narcissism is associated with severity of depressive symptoms in dysthymic patients. Psychiatry Res. 2017;257:265-9. FI:2,528(Q2). DOI:10.1016/j.psychres.2017.07.061.

Penas P, Moreno MC, Uriarte JJ, Ridgway P, Iraurgi I. How is evaluated mental health recovery?. Eur Psychiatry. 2017;41:199. FI:3,123(Q2). DOI:10.1016/j.eurpsy.2017.01.2145. ABSTRACT

Penas P, Uriarte JJ, Ridgway P, Moreno MC, Iraurgi I. Spanish adaptation of the recovery enhancing environments (REE) measure: Preliminary results. Eur Psychiatry. 2017;41:199. FI:3,123(Q2). DOI:10.1016/j.eurpsy.2017.01.2144. ABSTRACT

 

Ayesa-Arriola R, Rodriguez-Sanchez JM, Suero ES, Reeves LE, Tabares-Seisdedos R, Crespo-Facorro B. Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients. Eur Arch Psych Clin Neurosci. 2016;266:619-28. FI:3,569(Q2). DOI:10.1007/s00406-015-0667-0.

Ayesa-Arriola R, Setien-Suero E, Neergaard KD, Ferro A, Fatjo-Vilas M, Rios-Lago M, et al. Evidence for Trait Related Theory of Mind Impairment in First Episode Psychosis Patients and Its Relationship with Processing Speed: A 3 Year Follow-up Study. Front Psychol. 2016;7:592. FI:2,323(Q2). DOI:10.3389/fpsyg.2016.00592.

Calderón C, Balagué L, Iruin Á, Retolaza A, Belaunzaran J, Basterrechea J, et al. Primary care and mental health care collaboration in patients with depression: Evaluation of a pilot experience. Aten Primaria. 2016;48:356-65. FI:1,042(Q3). DOI:10.1016/j.aprim.2015.06.013. ABSTRACT

Cuellar AG, Pinto AG, Balsategui AR, Bacaicoa OA, Suarez JT, Zabala AF, et al. Deploying eHealth: A new approach to face depression. Int J Integr Care. 2016;16:UNSP S10. FI:2,230(Q2). DOI:10.5334/ijic.2557. ABSTRACT

Mayoral-van Son J, de la Foz VO, Martinez-Garcia O, Moreno T, Parrilla-Escobar M, Valdizan EM, et al. Clinical Outcome After Antipsychotic Treatment Discontinuation in Functionally Recovered First-Episode Nonaffective Psychosis Individuals: A 3-Year Naturalistic Follow-Up Study. J Clin Psychiatry. 2016;77:492-U111. FI:5,291(Q1). DOI:10.4088/JCP.14m09540.

Montero-Gonzalez G, Arnaiz A, Arrue A, Olivas O, Gordo E, Marin E, et al. Influence of genetic polymorphisms on hyperprolactinemia caused by risperidone or paliperidone and on the effect of adjunctive aripiprazole. Eur Neuropsychopharmacol. 2016;26:249-50. FI:4,239(Q1). DOI:10.1016/S0924-977X(16)31121-X. ABSTRACT

Peña J, Ibarretxe-Bilbao N, Sánchez P, Iriarte MB, Elizagarate E, Garay MA, et al. Combining social cognitive treatment, cognitive remediation, and functional skills training in schizophrenia: a randomized controlled trial. NPJ Schizophr. 2016;2:16037. DOI:10.1038/npjschz.2016.37.

Zumárraga M, Arrúe A, Basterreche N, Macías I, Catalán A, Madrazo A, et al. COMT haplotypes, catecholamine metabolites in plasma and clinical response in schizophrenic and bipolar patients. Pharmacogenomics. 2016;17:837-51. FI:2,350(Q3). DOI:10.2217/pgs-2016-0022.

 

Varela-Gomez N, Mata I, Perez-Iglesias R, Rodriguez-Sanchez JM, Ayesa R, Fatjo-Vilas M, et al. Dysbindin gene variability is associated with cognitive abnormalities in first-episode non-affective psychosis. Cogn Neuropsychiatry. 2015;20:144-156. FI:1,924(Q2). DOI: 10.1080/13546805.2014.991780.

Lertxundi U, Isla A, Solinis MA, Domingo-Echaburu S, Hernandez R, Peral-Aguirregoitia J, et al. Anticholinergic burden in Parkinson's disease inpatients. Eur J Clin Pharmacol. 2015;71:1271-7. FI:2,710(Q2). DOI:10.1007/s00228-015-1919-7.

Lertxundi U, Domingo-Echaburu S, Hernandez R, Peral-Aguirregoitia J, Medrano J. Confusion regarding anticholinergic burden measurement. J Am Geriatr Soc. 2015;63:1054. FI:3,842(Q1). DOI: 10.1111/jgs.13411.

Lertxundi U, Hernandez R, Medrano J, Domingo S, Ruiz B, Garcia M, et al. Possible interaction between letrozole and long-acting injectable zuclopenthixol. Nord J Psychiat. 2015;69:79-80. FI:1,273(Q3). DOI: 10.3109/08039488.2014.915341.

Roiz-Santiáñez R, Ortiz-García V, Ayesa-Arriola R, Tordesillas-Gutiérrez D, Jorge R, Varela-Gómez N, et al. No progression of the alterations in the cortical thickness of individuals with schizophrenia-spectrum disorder: a three-year longitudinal magnetic resonance imaging study of first-episode patients. Psychol Med. 2015;45:2861-71. FI:5,491(Q1). DOI:10.1017/S0033291715000811.

Solana B, Jorquera C, Gonzalez F, Vaccari F, Nieto A, Panera C, et al. Evaluation of an outpatient intensive care Program in Public Mental Health Services in Bizkaia (Basque Country) for children with severe developmental disorders: systematization, coordination and baseline for measuring evolution. Eur Child Adolesc Psych. 2015;24:115. FI:3,339(Q1). ABSTRACT

Gabilondo A, Gonzalez A, Retolaza A, Fullaondo A, Prieto L, Mora J, et al. Deploying eHealth to face depression. Int J Integr Care. 2015;15. FI:1,557(Q3). ABSTRACT

 

Lubrini G, Perianez JA, Rios-Lago M, Viejo-Sobera R, Ayesa-Arriola R, Sanchez-Cubillo I, et al. Clinical Spanish Norms of the Stroop Test for Traumatic Brain Injury and Schizophrenia. Span J Psychol. 2014;17:e96. FI:0,706(Q3).

Ayesa-Arriola R, Rodriguez-Sanchez JM, Gomez-Ruiz E, Roiz-Santiáñez R, Reeves LL, Crespo-Facorro B. No sex differences in neuropsychological performance in first episode psychosis patients. Prog Neuro-Psychopharmacol Biol Psychiatry. 2014;48:149-54. FI:3,689(Q1).

Gutiérrez-Fernández A, Palomino A, González-Pinto A, Ugarte A, Hernanz M, Mendibil B, et al. Novel association of Neuregulin 1 gene with bipolar disorder but not with schizophrenia. Schizophr Res. 2014;159:552-3. FI:3,923(Q1).

Ayesa-Arriola R, Morinigo JDL, David AS, Perez-Iglesias R, Rodriguez-Sanchez JM, Crespo-Facorro B. Lack of insight 3 years after first-episode psychosis: An unchangeable illness trait determined from first presentation?. Schizophr Res. 2014;157;271-7. FI:3,923(Q1).

Calderón C, Mosquera I, Balagué L, Retolaza A, Bacigalupe A, Belaunzaran J, et al. Models for Primary Care and Mental Health Collaboration in the Care of People with Depression: Main Results and Methodological Challenges of a Systematic Overview. Rev Esp Salud Publica. 2014;88:113-33. FI:0,600(Q4).

Arteagoitia I, Zumarraga M, Davila R, Barbier L, Santamaria G, Santamaria J. Plasma variations in stress markers: Clinical trial of two anesthetics used in regional block in the extraction of impacted inferior third molars. Med Oral Patol Oral Cir Bucal. 2014;19:274-9. FI:1,171(Q3).

 

Rodriguez-Sanchez JM, Ayesa-Arriola R, Perez-Iglesias R, Perianez JA, Martinez-Garcia O, Gomez-Ruiz E, et al. Course of cognitive deficits in first episode of non-affective psychosis: A 3-year follow-up study. Schizophr Res. 2013;150:121-8. FI:4,426(Q1).

Ayesa-Arriola R, Rodriguez-Sanchez JM, Perez-Iglesias R, Roiz-Santianez R, Martinez-Garcia O, Sanchez-Moreno J, et al. Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone. Psychopharmacology. 2013;227:615-25. FI:3,988(Q1).

Ayesa-Arriola R, Perez-Iglesias R, Rodriguez-Sanchez JM, Pardo-Garcia G, Tabares-Seisdedos R, Ayuso-Mateos JL, et al. Predictors of neurocognitive impairment at 3 years after a first episode non-affective psychosis. Prog Neuro-Psychopharmacol Biol Psychiatry. 2013;43:23-8. FI:4,025(Q1).

Ayesa-Arriola R, Rodriguez-Sanchez JM, Perez-Iglesias R, Gonzalez-Blanch C, Pardo-Garcia G, Tabares-Seisdedos Rl, et al. The relevance of cognitive, clinical and premorbid variables in predicting functional outcome for individuals with first-episode psychosis: A 3 year longitudinal study. Psychiatry Res. 2013;209:302-8. FI:2,682(Q2).

Davila W, Basterreche N, Arrue A, Zamalloa MI, Gordo E, Davila R, et al. The Influence of the Val158Met Catechol-O-Methyltransferase Polymorphism on the Personality Traits of Bipolar Patients. PLoS One. 2013; 8:e62900. FI:3,534(Q1).

Lertxundi U, Domingo-Echaburu S, Ruiz-Osante B, Hernandez R, Peral J, Medrano J. Comments on Duran et al.'s systematic review of anticholinergic risk scales. Eur J Clin Pharmacol. 2013;69:1729. FI:2,697(Q2).

Paya B, Rodriguez-Sanchez JM, Otero S, Munoz P, Castro-Fornieles J, Parellada M, et al. Premorbid impairments in early-onset psychosis: Differences between patients with schizophrenia and bipolar disorder. Schizophr Res. 2013;146:103-10. FI:4,426(Q1).

Torrecilla M, Fernández-Aedo I, Arrue A, Zumarraga M, Ugedo L. Role of GIRK channels on the noradrenergic transmission in vivo: an electrophysiological and neurochemical study on GIRK2 mutant mice. Int J Neuropsychopharmacol. 2013;16:1093-104. FI:5,264(Q1).

 

Tesis del grupo

Autor/a: June Corcuera Tejada. Título: "Revisiones sistemáticas y meta-análisis en modelos animales para la investigación traslacional de patologías psiquiátricas". Director/a: Dr. Francisco Javier Ballesteros Rodriguez.

Autor/a: Leire Erkoreka González. Título: Análisis exploratorio de la influencia sobre dimensiones de personalidad de polimorfismos genéticos funcionales de la catecol-o-metiltransferasa, el transportador de serotonina y la monoamino oxidasa-A, y su interacción con variables ambientales adversas. Un estudio en pacientes con trastornos de la personalidad y controles sanos. Director/a: Dr. Miguel Ángel González Torres, Dra. Mercedes Zumárraga.

© 2022 IIS Biocruces Bizkaia